CIK: 0000924020
Total reported value
$978.2M
Reporting period: 2021-06-30 · Number of holdings: 21
Johnson & Johnson Innovation - JJDC, Inc. disclosed 21 holdings in its latest 13F filing for the period ending 2021-06-30, with total reported value of $978.2M and a quarterly turnover rate of 88.2%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "J"
Sector classification currently covers about 28% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Sold out FATE
Sold out ARWR
Sold out PTGX
Sold out LEGN
Sold out VOR
Sold out MGTX
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | FATE | Fate Therapeutics INC | Stock-Other | 29.98% | -36.08% | EXIT | |
| 2 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 27.61% | -28.01% | EXIT | |
| 3 | PTGX | Protagonist Therapeutics INC | Stock-Other | 11.24% | -8.22% | EXIT | |
| 4 | CVRX | Cvrx INC | Stock-Other | 10.01% | — | — | |
| 5 | LEGN | Legend Biotech Corp-adr | Stock-Other | 6.84% | -6.12% | EXIT | |
| 6 | MGTX | MeiraGTx Holdings plc | Stock-Other | 4.59% | -5.42% | EXIT | |
| 7 | ✓ | Fusion Pharmaceuticals INC | Stock-Other | 3.03% | -5.10% | EXIT | |
| 8 | VOR | Vor Biopharma Inc. | Stock-Other | 2.05% | -6.00% | EXIT | |
| 9 | ✓ | Biomx INC | Stock-Other | 1.19% | -1.97% | EXIT | |
| 10 | ✓ | Therapeutics Acquisition Cor | Stock-Other | 1.05% | — | — | |
| 11 | TORCEUR | Adicet Bio INC | Stock-Other | 0.77% | -1.23% | EXIT | |
| 12 | PHASEUR | Phasebio Pharmaceuticals INC | Stock-Other | 0.61% | -0.72% | EXIT | |
| 13 | ALDX | Aldeyra Therapeutics INC | Stock-Other | 0.46% | -0.61% | EXIT | |
| 14 | CSLT1EUR | Castlight Health Inc-b | Stock-Other | 0.22% | -0.16% | EXIT | |
| 15 | NPCE | Neuropace INC | Stock-Other | 0.13% | — | — | |
| 16 | ZYUSD | Zymergen INC | Stock-Other | 0.07% | — | — | |
| 17 | ✓ | Stock-Other | 0.06% | -0.09% | EXIT | ||
| 18 | ✓ | Gyre Therapeutics INC Com | Stock-Other | 0.03% | -0.04% | EXIT | |
| 19 | ✓ | Graybug Vision INC Com | Stock-Other | 0.03% | -0.04% | EXIT | |
| 20 | LUNG | Pulmonx CORP | Stock-Other | 0.03% | -0.03% | EXIT | |
| 21 | SENS1GBP | Senseonics Holdings INC | Stock-Other | 0.02% | -0.17% | EXIT |
Not enough priced holdings yet to compute performance
Johnson & Johnson Innovation - JJDC, Inc.'s most significant position changes for 2021-06-30: Sold out: Fate Therapeutics INC (FATE); Sold out: Arrowhead Pharmaceuticals In (ARWR); Sold out: Protagonist Therapeutics INC (PTGX); Sold out: Legend Biotech Corp-adr (LEGN); Sold out: Vor Biopharma Inc. (VOR).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | FATE | Fate Therapeutics INC | — | EXIT | Sold out |
| 2 | ARWR | Arrowhead Pharmaceuticals In | — | EXIT | Sold out |
| 3 | PTGX | Protagonist Therapeutics INC | — | EXIT | Sold out |
| 4 | LEGN | Legend Biotech Corp-adr | — | EXIT | Sold out |
| 5 | VOR | Vor Biopharma Inc. | — | EXIT | Sold out |
| 6 | MGTX | MeiraGTx Holdings plc | — | EXIT | Sold out |
| 7 | ✓ | Fusion Pharmaceuticals INC | — | EXIT | Sold out |
| 8 | ✓ | Biomx INC | — | EXIT | Sold out |
| 9 | TORCEUR | Adicet Bio INC | — | EXIT | Sold out |
| 10 | PHASEUR | Phasebio Pharmaceuticals INC | — | EXIT | Sold out |
| 11 | ALDX | Aldeyra Therapeutics INC | — | EXIT | Sold out |
| 12 | SENS1GBP | Senseonics Holdings INC | — | EXIT | Sold out |
| 13 | CSLT1EUR | Castlight Health Inc-b | — | EXIT | Sold out |
| 14 | ✓ | — | EXIT | Sold out | |
| 15 | ✓ | Gyre Therapeutics INC Com | — | EXIT | Sold out |
| 16 | ✓ | Graybug Vision INC Com | — | EXIT | Sold out |
| 17 | LUNG | Pulmonx CORP | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2021-06-30 | 2021-08-03 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-06 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-09 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-03 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-12 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-13 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001965241
Total reported value
$977.0M
286 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001802167
Total reported value
$976.9M
211 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001865991
Total reported value
$976.9M
1 stks
2026-03-31
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0000200406
Total reported value
$652.4M
16 stks
2026-03-31
2 of the top 5 holdings overlap, including Protagonist Therapeutics INC
CIK 0000106077
Total reported value
$143.0M
93 stks
2022-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Arrowhead Pharmaceuticals In
CIK 0001028074
Total reported value
$246.5M
37 stks
2026-03-31
1 of the top 5 holdings overlap, including Legend Biotech Corp-adr